Furthermore, IL1 can induce LIF expression and activate downstream JAK/STAT to generate tumor-promoting CAFs subtype iCAFs, while TGF-β can antagonize this process by downregulating interleukin-1 receptor1 (IL1R1) expression and promoting differentiation into myCAFs [30]. This evidence concerns the gene IL1B and neoplasm.